Acetyl-L-Carnitine के लिए Age-Related Cognitive Decline

Mixed results in healthy adults but more consistently positive outcomes in elderly populations with existing cognitive concerns. Used as a prescription drug in some European countries for cognitive impairment.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dacetyl\u002Dl\u002Dcarnitine\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

निष्कर्ष

Key Study Findings

Randomized Controlled Trial

Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized …

Dose: None बनाम: None Outcome: Cognitive decline प्रभाव: None None

जनसंख्या: Alzheimer's disease patients

Systematic Review

Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update.

Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Review

Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies.

Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Chronic pain patients (preclinical review)

Review

Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy …

Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Parkinson's disease patients

Controlled Clinical Trial

Effect of mitochondrial cofactors and antioxidants supplementation on cognition in the aged canine.

Dose: mitochondrial cofactors + antioxidants बनाम: control diet Outcome: cognitive function in aged dogs प्रभाव: improved learning and memory None

जनसंख्या: Aged beagle dogs

Randomized Controlled Trial n=106 Double-blind

A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in …

Dose: None बनाम: placebo Outcome: None प्रभाव: None p = 0.0083

जनसंख्या: Alzheimer's disease patients

Key Statistics

अध्ययन

1000

प्रतिभागी

↑

Positive

ग्रेड

Referenced Papers

Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial. RCT

Medicine 2024 3 उद्धरण

Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update. Review

Nutrients 2020 72 उद्धरण

Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management. Review

Ageing research reviews 2017 56 उद्धरण

Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies. Other

Journal of pain … 2017 49 उद्धरण

Effect of mitochondrial cofactors and antioxidants supplementation on cognition in the aged canine. Other

Neurobiology of aging 2016 19 उद्धरण

A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease. RCT

Journal of Alzheimer's … 2015 112 उद्धरण

Pharmacological interventions for cognitive decline in people with Down syndrome. Meta-Analysis

The Cochrane database … 2015 33 उद्धरण

n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. Other

Frontiers in aging … 2014 111 उद्धरण

A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia. RCT

The journal of … 2010 70 उद्धरण

Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain … Other

Nutrition research (New … 2009 65 उद्धरण

Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Review

Alternative medicine review … 2008

Acetyl-L-carnitine and alpha-lipoic acid supplementation of aged beagle dogs improves learning in two landmark discrimination tests. Other

FASEB journal : … 2007 52 उद्धरण

Acetyl-L-carnitine for dementia. Systematic Review

The Cochrane database … 2003 94 उद्धरण

A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Review

Alternative medicine review … 1999 112 उद्धरण

[Methodology of a clinical controlled study of L-acetylcarnitine]. CCT

La Clinica terapeutica 1990 3 उद्धरण

Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome. RCT

International journal of … 1990

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:: 500-2,000 mg/day
cognitivesupport:: 1,500-3,000 mg/day

अधिकतम सीमा: Well-tolerated up to 3,000 mg/day

अनुसंधान में अध्ययन की गई खुराकें

खुराक	अवधि	प्रभाव	N
None	--	Positive	--
None	--	Positive	--
None	--	Mixed	--
None	--	Mixed	--
mitochondrial cofactors + antioxidants	--	Positive	--
None	--	Positive	106
None	--	Positive	427
None	8.0 weeks	Positive	--

सेवन का सर्वोत्तम समय: Morning, on empty stomach or with meals

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

⚠ Gastrointestinal discomfort (nausea, vomiting, diarrhea)
⚠ Fishy body odor
⚠ Restlessness or insomnia
⚠ Increased appetite

ज्ञात अंतःक्रियाएँ

● Anticoagulants (may increase bleeding risk)
● Thyroid medications (may enhance thyroid hormone effects)
● AZT (antiretroviral — may reduce neuropathy)

सहनीय अधिकतम सेवन: Well-tolerated up to 3,000 mg/day

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Acetyl-L-Carnitine help with Age-Related Cognitive Decline?

Based on 14 studies with 1,000 participants, there is limited but promising evidence that Acetyl-L-Carnitine may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).

How much Acetyl-L-Carnitine should I take for Age-Related Cognitive Decline?

Studies have used various dosages. A commonly studied range is 500-2,000 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Acetyl-L-Carnitine?

Reported side effects may include Gastrointestinal discomfort (nausea, vomiting, diarrhea), Fishy body odor, Restlessness or insomnia, Increased appetite. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Acetyl-L-Carnitine and Age-Related Cognitive Decline?

We rate the evidence as Grade C (Some Evidence). This rating is based on 14 peer-reviewed studies with 1,000 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Age-Related Cognitive Decline

Omega-3 Fatty Acids (DHA/EPA) A Phosphatidylserine B Bacopa monnieri B Vitamin B12 B Curcumin B Ginkgo biloba C

Acetyl-L-Carnitine अन्य स्वास्थ्य स्थितियों के लिए

Oxidative Stress & Neuroinflammation C

संक्षिप्त निष्कर्ष

Evidence Strength52%

Moderate confidence

अध्ययन विश्लेषण

RCT (4)Meta (1)Other (9)

विकल्पों की तुलना करें

देखें कि इस स्वास्थ्य स्थिति के लिए अन्य सामग्री की तुलना कैसे है।

इसके लिए सभी सामग्री देखें Age-Related Cognitive Decline

अधिक जानें

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।